IBB — iShares Nasdaq Biotechnology ETF
—
NMS ·
Health Care ·
Developed Markets ·
CIK ·
Last close
—
Market Cap
—
52W High
—
52W Low
—
ADV30
—
Next earnings
—
No quarterly fundamentals indexed for this ticker.
Max Pain — expiry 2026-12-18
max pain strike: $205.00 · spot: $205.39 · call oi: 4,520 · put oi: 14,011
Expected Move to 2026-12-18:
±$13.50
(6.57%) —
implied range
$191.89 –
$218.89
· ATM straddle on $205.00 strike
News headlines (Yahoo Finance, 1h cache)
iShares Biotechnology ETF (IBB) Buys $16.2 Million More Gilead on Nov. 16
2026-11-18 11:05 · Yahoo
What iShares Biotechnology ETF (IBB) Bought: Gilead Leads on Nov. 13
2026-11-17 11:05 · Yahoo
While AI hogged the headlines, 1 overlooked sector beat the S&P 500 — and its top stock is up 700%+ this year
2026-11-13 12:00 · Yahoo
The AI Debt Bill Is Coming Due, But Biotech Has Revenue to Show for the Boom
2026-11-11 13:10 · Yahoo
iShares Biotechnology ETF (IBB) Adds Gilead and Amgen on Nov. 9
2026-11-11 11:04 · Yahoo
Healthcare ETFs in 2026: Biotech Leads, Medical Devices Lag
2026-11-03 19:18 · Yahoo
Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now?
2026-11-02 10:20 · Yahoo
Regeneron Surges 13.55%: Here’s What It Means for Your Health Care ETFs
2026-10-30 15:18 · Yahoo
Should You Invest in the iShares Biotechnology ETF (IBB)?
2026-10-29 09:20 · Yahoo
ETFs That You May Consider Amid a Strengthening Biotech Outlook
2026-10-28 14:06 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.